Indeed, the loss of S1PR2 induces the expansion of intestinal stem cells in colon cancer cells and, clinically, S1PR2 expression was lost in 33% of adenocarcinomas with stage II/III pT3-T4 and significantly decreased in 55% [159]. The gene discussed is S1PR2; the disease is malignant colon neoplasm.